Patient Education and Counseling
Volume 63, Issue 3 , Pages 367-379 , November 2006

Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: A randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested

  • Eila Watson

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Department of Primary Health Care, University of Oxford, Old Rd Campus, Headington, Oxford OX3 7LF, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 1865 226 788; fax: +44 1865 226 784.
    • ,
  • Paul Hewitson

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Department of Primary Health Care, University of Oxford, Old Rd Campus, Headington, Oxford OX3 7LF, United Kingdom
    • ,
  • Joanne Brett

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Department of Primary Health Care, University of Oxford, Old Rd Campus, Headington, Oxford OX3 7LF, United Kingdom
    • ,
  • Colleen Bukach

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Department of Primary Health Care, University of Oxford, Old Rd Campus, Headington, Oxford OX3 7LF, United Kingdom
    • ,
  • Rhodri Evans

      Affiliations

    • Centre for Health Sciences Research, Cardiff University, Cardiff, United Kingdom
    • ,
  • Adrian Edwards

      Affiliations

    • Centre for Health Sciences Research, Cardiff University, Cardiff, United Kingdom
    • ,
  • Glyn Elwyn

      Affiliations

    • Centre for Health Sciences Research, Cardiff University, Cardiff, United Kingdom
    • ,
  • Anna Cargill

      Affiliations

    • Centre for Statistics in Medicine, University of Oxford, United Kingdom
    • ,
  • Joan Austoker

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Department of Primary Health Care, University of Oxford, Old Rd Campus, Headington, Oxford OX3 7LF, United Kingdom

Received 19 January 2006 ,Revised 27 April 2006 ,Accepted 1 May 2006.

References 

  1. Cancer Research UK . Prostate CancerStats. London: Cancer Research UK; 2002;
  2. Neal DE, Donovan JL. Prostate cancer: to screen or not to screen?. Lancet Oncol. 2000;1:17–24
  3. Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. Eff Clin Pract. 2001;4:112–120
  4. Volk RJ, Cass AR, Spann SJ. A randomized, controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8:333–340
  5. Partin MR, Nelson D, Radosevich D, Nugent S, Flood AB, Dillon N, et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Int Med. 2004;19:835–842
  6. Frosch DL, Kaplan RM, Felitti V. Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Int Med. 2001;16:391–398
  7. Berglund G, Nilsson S, Nordin K. Intention to test for prostate cancer. Eur J Cancer. 2005;41:990–997
  8. Gattellari M, Ward JE. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen. 2003;10:27–39
  9. National Screening Committee. Prostate Cancer Risk Management Programme. August, 2001.
  10. Watson E, Jenkins L, Bukach C, Brett J, Austoker J. Prostate cancer risk management programme: an information pack for primary care. Sheffield: NHS Cancer Screening Programmes; 2002;
  11. National Screening Committee. Second Report of the National Screening Committee. London: Department of Health; 2000.
  12. Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26:67–80
  13. Evans R, Edwards A, Brett J, Bradburn M, Watson E, Austoker J, et al. Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations. Patient Educ Counsel. 2005;58:13–26
  14. Chiu BC, Anderson JR, Corbin D. Predictors of prostate cancer screening among health fair participants. Public Health. 2005;119:686–693
  15. Pinnock CB, Weller DP, Marshall VR. Self-reported prevalence of prostate-specific antigen testing in South Australia: a Community study. MJA. 1998;169:25–28
  16. Ubel PA. Is information always a good thing? Helping patients make “good” decisions. Med Care. 2002;40:V39–V44
  17. O’Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions (Cochrane Review). Cochrane Database Syst Rev. 2001;
  18. Duman MFC. The POPPi Guide. Practicalities of producing patient information. London: King's Fund; 2000;
  19. Rakowski W, Andersen MR, Stoddard AM, Urban N, Rimer BK, Lane DS, et al. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol. 1997;16:433–441
  20. Degner L, Sloan J, Venkatesh P. The control preferences scale. Canadian Journal of Nursing Research. 1997;29:21–43
  21. Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549–1557
  22. Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York; 2006.
  23. Schafer JL. Analysis of incomplete multivariate data. New York; 1997.
  24. Lechner L, de Vries H, Offermans N. Participation in a breast cancer screening program: influence of past behaviour and determinants on future screening participation. Prev Med. 2006;26:473–482
  25. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med. 2003;36:525–535
  26. Brett J. A multi-centre follow-up study to assess the anxiety and opinions of women one month before their next routine breast screening appointment, having previously attended three years earlier. University of Oxford; 1999;
  27. Hewitson P, Austoker J. Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. BJU Int. 2005;95:16–32
  28. Sheridan SL, Felix K, Pignone MP, Lewis CL. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid. Patient Educ Counsel. 2004;54:345–351
  29. Edwards A, Elwyn G, Hood K, Atwell C, Robling M, Houston H, et al. Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Family Practice. 2004;21:347–354
  30. O’Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. Brit Med J Clinical Research Ed. 2003;327:736–740
  31. Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O’Neil J, et al. Information needs and decisional preferences in women with breast cancer. J Am Med. 1997;277:1485–1492
  32. Austoker J. In:  Austoker J,  Patnick J editor. Breast screening acceptability: research and practice. vol. 28:Sheffield: NHSBSP Publications; 1993;p. 34–59
  33. Fox SA, Murata PJ, Stein JA. The impact of physician compliance on screening mammography for older women. Arch Int Med. 1991;151:50–56
  34. Launoy G, Veret JL, Richir B, Reaud JM, Ollivier V, Valla A, et al. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France). Eur J Cancer Prev. 1993;2:229–232

PII: S0738-3991(06)00159-5

doi: 10.1016/j.pec.2006.05.005

Patient Education and Counseling
Volume 63, Issue 3 , Pages 367-379 , November 2006

Article Tools

* Image Usage & Resolution